Results 161 to 170 of about 4,481,490 (243)
Modulation of plasma matrix metalloproteinase 9 and its inhibitors by vitamin D. [PDF]
PhDMatrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are upregulated in a variety of diseases. Hypothesis: As TIMP-1 levels are elevated in liver fibrosis, might a similar process occur in essential hypertension driven left ...
Timms, Peter McLean
core
A Ten Year Overview of Adrenal Vein Sampling in Croatia: Insights and Outcomes
ABSTRACT Background Adrenal vein sampling (AVS) is the gold standard for subtype differentiation in primary aldosteronism (PA), yet it remains technically demanding and resource intensive. However, data on long‐term performance, learning curves, and concordance with imaging in real‐world clinical practice are limited.
Karin Zibar Tomsic +4 more
wiley +1 more source
Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund +5 more
wiley +1 more source
INFLUENCE OF HEMODIALYSIS ON PLASMA ALDOSTERONE CONCENTRATION IN NEPHRECTOMIZED PATIENTS
R E, McCaa +3 more
openaire +3 more sources
Increased Plasma Aldosterone Concentration In Response to Hemodialysis In Nephrectomized Man
R. McCaa +4 more
semanticscholar +1 more source
Primary Hyperaldosteronism Due to Adrenocortical Adenoma: a Case Report
Primary hyperaldosteronism is an adrenal abnormality in which there is some degree of autonomy of aldosterone secretion. We report a case of thirty three years old Javanese female presented with uncontrolled hypertension, muscular weakness, cramps and ...
Tjokorda Gde Dalem Pemayun +4 more
doaj
Regulation of plasma aldosterone concentration in anephric man and renal transplant recipients.
C. Cooke +4 more
semanticscholar +1 more source
This study examined the involvement of fibroblast growth factor-23 (FGF-23) in primary aldosteronism (PA), a condition characterized by elevated aldosterone levels and hypertension.
Vin-Cent Wu +8 more
doaj +1 more source

